The only thing better than finding a cure for a disease is preventing illness in the first place.
Nothing prevents viral or bacterial infections quite as well as a vaccine, which trains the human immune system to attack invading microbes before they can establish themselves in the body and cause diseases that can lead to death or a lifetime of disability.
Visit the investors corner.
Corporate citizenship at Novartis is an integral part of how we operate and a key to our success.
Novartis Vaccines Inc. is committed to establishing and maintaining an effective Integrity and Compliance Program.
Today, Novartis Vaccines has a strong global presence, most notably in Europe, with its centers of excellence in Germany, Italy and the UK.
A solid emphasis on research and a never-ending commitment to preventing disease have been the driving forces at Novartis Vaccines.
At Novartis Vaccines, we feel privileged to be working in a field where we can truly make a difference in protecting the lives of so many people from infection and disease.
The Novartis Vaccines Grant Request Review Committee (GRRC) reviews requests for non-promotional continuing medical education (CME) programs from accredited and non-accredited providers, as well as patient advocacy and education / outreach initiatives from certified 501(c)3 organizations.
Discover up-to-date Novartis Vaccines information.
Business Development & Licensing
Finding new partnership to develop new vaccines is one of the BD&L team mission.
Disease & products
Learn about meningitis, influenza, rabies, TBE and japanese encephalities.